A novel protein tyrosine kinase NOK that shares homology with platelet- derived growth factor/fibroblast growth factor receptors induces tumorigenesis and metastasis in nude mice - PubMed (original) (raw)
. 2004 May 15;64(10):3491-9.
doi: 10.1158/0008-5472.CAN-03-2106.
Xin-Zi Yu, Tie-Shi Li, Lian-Xia Song, Pei-La Chen, Ta-Lin Suo, Ying-Hua Li, Shi-Dong Wang, Yue Chen, Yong-Ming Ren, Shu-Ping Zhang, Zhi-Jie Chang, Xin-Yuan Fu
Affiliations
- PMID: 15150103
- DOI: 10.1158/0008-5472.CAN-03-2106
A novel protein tyrosine kinase NOK that shares homology with platelet- derived growth factor/fibroblast growth factor receptors induces tumorigenesis and metastasis in nude mice
Li Liu et al. Cancer Res. 2004.
Abstract
Receptor protein tyrosine kinases (RPTKs) play important roles in the regulation of a variety of cellular processes including cell migration, proliferation, and protection from apoptosis. Here, we report the identification and characterization of a novel RPTK-like molecule that has a critical role in induction of tumorigenesis and metastasis and is termed Novel Oncogene with Kinase-domain (NOK). NOK contains a putative single transmembrane domain and a conserved intracellular tyrosine kinase domain that shares homology with members of the platelet-derived growth factor/fibroblast growth factor receptor superfamily. NOK was exclusively located in the cytoplasm. NOK mRNAs were detected in limited human organs and expressed with the highest abundance in the prostate. A variety of tumor cells also expressed the NOK mRNAs. We demonstrated that NIH3T3 and BaF3 cells could be strongly transformed by the expression of the NOK gene as examined by colony formation experiment. In addition, BaF3 cells with the stable expression of NOK induced rapid tumorigenesis in nude mice. Interestingly, these NOK-expressing tumor cells could promptly invade and spread into various distinct organs and form metastatic foci, eventually leading to the rapid death of these animals. Moreover, molecular mechanism studies indicated that NOK could concomitantly activate both MAP kinase and phosphatidylinositol 3'-kinases (PI3K) pathways in stable BaF3 cells. Thus, our results both in vitro and in vivo suggest that NOK is a novel oncogene with the capacity of promoting cell transformation, tumorigenesis, and metastasis.
Similar articles
- Point mutation at single tyrosine residue of novel oncogene NOK abrogates tumorigenesis in nude mice.
Chen Y, Li YH, Chen XP, Gong LM, Zhang SP, Chang ZJ, Zhang XF, Fu XY, Liu L. Chen Y, et al. Cancer Res. 2005 Dec 1;65(23):10838-46. doi: 10.1158/0008-5472.CAN-05-1091. Cancer Res. 2005. PMID: 16322230 - The carboxyl terminal tyrosine 417 residue of NOK has an autoinhibitory effect on NOK-mediated signaling transductions.
Li YH, Zhong S, Rong ZL, Ren YM, Li ZY, Zhang SP, Chang Z, Liu L. Li YH, et al. Biochem Biophys Res Commun. 2007 May 4;356(2):444-9. doi: 10.1016/j.bbrc.2007.02.154. Epub 2007 Mar 8. Biochem Biophys Res Commun. 2007. PMID: 17367757 - Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
Rusyn EV, Reynolds ER, Shao H, Grana TM, Chan TO, Andres DA, Cox AD. Rusyn EV, et al. Oncogene. 2000 Sep 28;19(41):4685-94. doi: 10.1038/sj.onc.1203836. Oncogene. 2000. PMID: 11032018 - Virocrine transformation: the intersection between viral transforming proteins and cellular signal transduction pathways.
DiMaio D, Lai CC, Klein O. DiMaio D, et al. Annu Rev Microbiol. 1998;52:397-421. doi: 10.1146/annurev.micro.52.1.397. Annu Rev Microbiol. 1998. PMID: 9891803 Review. - Met-related receptor tyrosine kinase Ron in tumor growth and metastasis.
Wagh PK, Peace BE, Waltz SE. Wagh PK, et al. Adv Cancer Res. 2008;100:1-33. doi: 10.1016/S0065-230X(08)00001-8. Adv Cancer Res. 2008. PMID: 18620091 Free PMC article. Review.
Cited by
- STYK1 mediates NK cell anti-tumor response through regulating CCR2 and trafficking.
He J, He Y, Biao R, Wei Y, Dong Z, Du J. He J, et al. J Transl Med. 2024 Oct 16;22(1):943. doi: 10.1186/s12967-024-05718-2. J Transl Med. 2024. PMID: 39415235 Free PMC article. - Therapeutic advances of targeting receptor tyrosine kinases in cancer.
Tomuleasa C, Tigu AB, Munteanu R, Moldovan CS, Kegyes D, Onaciu A, Gulei D, Ghiaur G, Einsele H, Croce CM. Tomuleasa C, et al. Signal Transduct Target Ther. 2024 Aug 14;9(1):201. doi: 10.1038/s41392-024-01899-w. Signal Transduct Target Ther. 2024. PMID: 39138146 Free PMC article. Review. - The malignant transformation potential of the oncogene STYK1/NOK at early lymphocyte development in transgenic mice.
Yang Y, Liu L, Tucker HO. Yang Y, et al. Biochem Biophys Rep. 2024 Apr 12;38:101709. doi: 10.1016/j.bbrep.2024.101709. eCollection 2024 Jul. Biochem Biophys Rep. 2024. PMID: 38638675 Free PMC article. - Ferroptosis in lung cancer: a novel pathway regulating cell death and a promising target for drug therapy.
Xing N, Du Q, Guo S, Xiang G, Zhang Y, Meng X, Xiang L, Wang S. Xing N, et al. Cell Death Discov. 2023 Apr 1;9(1):110. doi: 10.1038/s41420-023-01407-z. Cell Death Discov. 2023. PMID: 37005430 Free PMC article. Review. - STYK1/NOK affects cell cycle late mitosis and directly interacts with anaphase-promoting complex activator CDH1.
Zeng SL, Patel SS, Lv MQ, Zhu D, Shen WH, Liu L. Zeng SL, et al. Heliyon. 2022 Dec 5;8(12):e12058. doi: 10.1016/j.heliyon.2022.e12058. eCollection 2022 Dec. Heliyon. 2022. PMID: 36506394 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases